Boston Scientific Corp
BSX· NYSE
BSXBoston Scientific Corp
Quarterly figures for Boston Scientific Corp, with source filings when available.
73 quarters. Jun 30, 2008 to Jun 30, 2026. USD.
Boston Scientific Corp has filed its 10-Q within 31 to 34 days of period end across its last 8 quarters. The 10-K runs 19 to 54 days.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Jul 29, 2026 · pre-market | Aug 3, 2026 | 34 d | 10-Q | $5.44B | +7.5% | $0.61 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| Apr 22, 2026 · pre-market |
| May 1, 2026 |
| 31 d |
| 10-Q |
| $5.20B |
| +11.6% |
| $0.90 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 4, 2026 · pre-market | Feb 17, 2026 | 48 d | 10-K | $5.29B | +15.8% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 22, 2025 · pre-market | Nov 3, 2025 | 34 d | 10-Q | $5.07B | +20.3% | $0.51 | |
| Q2 2025 | Jun 30, 2025 | Jul 23, 2025 · pre-market | Aug 1, 2025 | 32 d | 10-Q | $5.06B | +22.8% | $0.53 | |
| Q1 2025 | Mar 31, 2025 | Apr 23, 2025 · pre-market | May 1, 2025 | 31 d | 10-Q | $4.66B | +20.9% | $0.45 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 5, 2025 · pre-market | Feb 18, 2025 | 49 d | 10-K | $4.56B | +22.5% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 23, 2024 · pre-market | Nov 1, 2024 | 32 d | 10-Q | $4.21B | +19.3% | $0.32 | |
| Q2 2024 | Jun 30, 2024 | Jul 24, 2024 · pre-market | Aug 1, 2024 | 32 d | 10-Q | $4.12B | +14.5% | $0.22 | |
| Q1 2024 | Mar 31, 2024 | Apr 24, 2024 · pre-market | May 1, 2024 | 31 d | 10-Q | $3.86B | +13.8% | $0.33 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Jan 31, 2024 · pre-market | Feb 20, 2024 | 51 d | 10-K | $3.73B | +14.9% | — | |
| Q3 2023 | Sep 30, 2023 | Oct 26, 2023 · pre-market | Nov 1, 2023 | 32 d | 10-Q | $3.53B | +11.3% | $0.34 | |
| Q2 2023 | Jun 30, 2023 | Jul 27, 2023 · pre-market | Aug 3, 2023 | 34 d | 10-Q | $3.60B | +10.9% | $0.18 | |
| Q1 2023 | Mar 31, 2023 | Apr 26, 2023 · pre-market | May 4, 2023 | 34 d | 10-Q | $3.39B | +12.0% | $0.21 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 1, 2023 · pre-market | Feb 23, 2023 | 54 d | 10-K | $3.24B | +3.7% | — | |
| Q3 2022 | Sep 30, 2022 | Oct 26, 2022 · pre-market | Nov 3, 2022 | 34 d | 10-Q | $3.17B | +8.1% | $0.12 | |
| Q2 2022 | Jun 30, 2022 | Jul 27, 2022 · pre-market | Aug 4, 2022 | 35 d | 10-Q | $3.24B | +5.4% | $0.17 | |
| Q1 2022 | Mar 31, 2022 | Apr 27, 2022 · pre-market | May 5, 2022 | 35 d | 10-Q | $3.03B | +10.0% | $0.07 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 2, 2022 · pre-market | Feb 23, 2022 | 54 d | 10-K | $3.13B | +15.5% | — | |
| Q3 2021 | Sep 30, 2021 | Oct 27, 2021 · pre-market | Nov 4, 2021 | 35 d | 10-Q | $2.93B | +10.3% | $0.28 | |
| Q2 2021 | Jun 30, 2021 | Jul 27, 2021 · pre-market | Aug 6, 2021 | 37 d | 10-Q | $3.08B | +53.6% | $0.12 | |
| Q1 2021 | Mar 31, 2021 | Apr 28, 2021 · pre-market | May 6, 2021 | 36 d | 10-Q | $2.75B | +8.2% | $0.23 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Feb 3, 2021 · pre-market | Feb 23, 2021 | 54 d | 10-K | $2.71B | −6.7% | — | |
| Q3 2020 | Sep 30, 2020 | Oct 28, 2020 · pre-market | Nov 5, 2020 | 36 d | 10-Q | $2.66B | −1.8% | -$0.12 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 5, 2020 | 36 d | 10-Q | $2.00B | −23.9% | -$0.11 | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $2.54B | +2.0% | $0.01 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | — | — | — | $2.90B | +13.4% | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | $2.71B | +13.1% | $0.09 | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | $2.63B | +5.7% | $0.11 | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | $2.49B | +4.8% | $0.30 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | — | — | — | $2.56B | +8.2% | — | |
| Q3 2018 | Sep 30, 2018 | — | — | — | — | $2.39B | +7.7% | $0.31 | |
| Q2 2018 | Jun 30, 2018 | — | — | — | — | $2.49B | +10.3% | $0.40 | |
| Q1 2018 | Mar 31, 2018 | — | — | — | — | $2.38B | +8.1% | $0.21 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | — | — | — | $2.37B | +9.4% | — | |
| Q3 2017 | Sep 30, 2017 | — | — | — | — | $2.22B | +6.0% | $0.20 | |
| Q2 2017 | Jun 30, 2017 | — | — | — | — | $2.26B | +6.1% | $0.11 | |
| Q1 2017 | Mar 31, 2017 | — | — | — | — | $2.20B | +10.2% | $0.21 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | — | — | — | $2.17B | +0.3% | — | |
| Q3 2016 | Sep 30, 2016 | — | — | — | — | $2.10B | +2.8% | $0.17 | |
| Q2 2016 | Jun 30, 2016 | — | — | — | — | $2.13B | +7.4% | -$0.15 | |
| Q1 2016 | Mar 31, 2016 | — | — | — | — | $2.00B | +5.7% | $0.15 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | — | — | — | $2.16B | +10.4% | — | |
| Q3 2015 | Sep 30, 2015 | — | — | — | — | $2.04B | +9.6% | -$0.15 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $1.98B | +6.0% | $0.08 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $1.89B | +6.4% | $0.00 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | — | — | — | $1.96B | +6.6% | — | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | $1.86B | +6.9% | $0.03 | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | $1.87B | +4.3% | $0.00 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $1.78B | +4.2% | $0.10 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | Feb 22, 2013 | -312 d | 10-K | $1.83B | +19.9% | — | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $1.74B | +0.3% | $0.00 | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $1.79B | −2.0% | $0.10 | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | $1.71B | −8.6% | -$0.26 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | — | — | — | $1.53B | −17.3% | — | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $1.74B | −7.4% | -$0.48 | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $1.83B | −7.4% | -$2.51 | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $1.87B | −3.1% | $0.08 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | — | — | — | $1.85B | −7.7% | — | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | $1.87B | −2.2% | $0.09 | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | $1.98B | +2.4% | $0.10 | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | $1.93B | −1.8% | $0.03 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010 | Dec 31, 2010 | — | — | — | — | $2.00B | −3.7% | $0.15 | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $1.92B | −5.4% | $0.12 | |
| Q2 2010 | Jun 30, 2010 | — | Aug 5, 2010 | 36 d | 10-Q | $1.93B | −7.0% | $0.06 | |
| Q1 2010 | Mar 31, 2010 | — | May 6, 2010 | 36 d | 10-Q | $1.96B | −2.5% | -$1.05 | |
| FY 2009 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2009 | Dec 31, 2009 | — | — | — | — | $2.08B | — | -$0.71 | |
| Q3 2009 | Sep 30, 2009 | — | — | — | — | $2.03B | +2.4% | -$0.06 | |
| Q2 2009 | Jun 30, 2009 | — | — | — | — | $2.07B | +2.5% | $0.10 | |
| Q1 2009 | Mar 31, 2009 | — | — | — | — | $2.01B | — | -$0.01 | |
| FY 2008 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2008derived | Dec 31, 2008 | — | — | — | — | — | — | — | |
| Q3 2008 | Sep 30, 2008 | — | — | — | — | $1.98B | — | -$0.04 | |
| Q2 2008 | Jun 30, 2008 | — | — | — | — | $2.02B | — | $0.07 | |
